Better Therapeutics, Inc.: Nasdaq/NYSE listing notice — Better Therapeutics to terminate employees, seek wind-down or sale after Nasdaq delisting

Better Therapeutics, Inc.

Board decided March 13, 2024 to terminate all employees and explore strategic alternatives including assignment for creditors or wind-down.
Company voluntarily requested delisting from Nasdaq; expects near-term delisting and intends to file Form 15 to suspend SEC reporting.
No financial terms disclosed; company had been non-compliant with Nasdaq min bid price and market value since Dec 2023.
Stock symbol BTTX on Nasdaq Capital Market.

item 3.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Better Therapeutics, Inc. received a nasdaq delisting notice notice regarding minimum bid price.

Exchange: nasdaq
Notice: delisting notice
Deficiency: minimum bid price

Exact text from the filing

March 14, 2024. On March 14, 2024, the Company has voluntarily requested a delisting of its securities and expects its securities to be delisted in the near term. The Company further intends to file a Form 15 with the Securities and Exchange Commission to suspend its reporting obligations under the Securities Exchange Act of 1934, as amended.

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001193125-24-067483

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.